Genetic and epigenetic changes in lung carcinoma and their clinical implications

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Modern Pathology

• Publication date

  2011-03-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/modpathol.2011.46PMID 21423157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrant methylation of SPARC in human lung cancers

  2013cited by this paper
• Lung cancer in never smokers--a review.

  2012cited by this paper
• PTEN, RASSF1 and DAPK site‐specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients

  2010cited by this paper
• miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.

  2010cited by this paper
• MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.

  2010cited by this paper
• Epigenetics in cancer.

  2010cited by this paper
• Lung cancer: From single-gene methylation to methylome profiling

  2010cited by this paper
• The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients.

  2010cited by this paper
• Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

  2010cited by this paper
• Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

  2010cited by this paper
• MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis.

  2010cited by this paper
• Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene

  2010cited by this paper
• Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer.

  2010cited by this paper
• Accurate Classification of Non–Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach

  2010cited by this paper
• MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.

  2009cited by this paper
• HDAC family: What are the cancer relevant targets?

  2009cited by this paper
• miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

  2009cited by this paper
• Effect of IFN-β on human glioma cell lines with temozolomide resistance

  2009cited by this paper
• Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers.

  2009cited by this paper
• RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China

  2009cited by this paper
• Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers.

  2009cited by this paper
• Potential Increase in the Prognostic Value of p53 Mutation by Pro72 Allele in Stage I Non-Small-Cell Lung Cancer

  2009cited by this paper
• Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population

  2009cited by this paper
• Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma

  2009cited by this paper
• Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway.

  2009cited by this paper
• Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

  2009cited by this paper
• MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo.

  2009cited by this paper
• Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.

  2009cited by this paper
• Let‐7a elevates p21WAF1 levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells

  2009cited by this paper
• Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion

  2009cited by this paper
• Effect of IFN-beta on human glioma cell lines with temozolomide resistance.

  2009cited by this paper
• Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors.

  2009cited by this paper
• ErbBs in lung cancer.

  2009cited by this paper
• miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.

  2009cited by this paper
• Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)

  2009cited by this paper
• MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.

  2009cited by this paper
• EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues.

  2009cited by this paper
• Global levels of histone modifications predict prognosis in different cancers.

  2009cited by this paper
• DNA methylation markers and early recurrence in stage I lung cancer.

  2008cited by this paper
• Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis.

  2008cited by this paper
• DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma

  2008cited by this paper
• The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

  2008cited by this paper
• LKB1; linking cell structure and tumor suppression

  2008cited by this paper
• The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development

  2008cited by this paper
• MicroRNA‐183 regulates Ezrin expression in lung cancer cells

  2008cited by this paper
• Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.

  2008cited by this paper
• Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma

  2008cited by this paper
• Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.

  2008cited by this paper
• EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers

  2008cited by this paper
• Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.

  2008cited by this paper
• MicroRNA signature predicts survival and relapse in lung cancer.

  2008cited by this paper
• Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer

  2008cited by this paper
• MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.

  2008cited by this paper
• Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors.

  2008cited by this paper
• 3p22.1 and 10q22.3 Deletions Detected by Fluorescence In Situ Hybridization (FISH): A Potential New Tool for Early Detection of Non-small Cell Lung Cancer (NSCLC)

  2008cited by this paper
• EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.

  2008cited by this paper
• FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer.

  2008cited by this paper
• Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer.

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Prevalence and specificity of LKB1 genetic alterations in lung cancers

  2007cited by this paper
• MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

  2007cited by this paper
• Lung cancer in never smokers: a review.

  2007cited by this paper
• Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.

  2007cited by this paper
• LKB1 modulates lung cancer differentiation and metastasis

  2007cited by this paper
• Cancer epigenomics: DNA methylomes and histone-modification maps

  2007cited by this paper
• Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer.

  2007cited by this paper
• EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.

  2007cited by this paper
• Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.

  2007cited by this paper
• Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• ErbB4 expression and mutation in Japanese patients with lung cancer.

  2007cited by this paper
• Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.

  2007cited by this paper
• KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

  2007cited by this paper
• Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.

  2007cited by this paper
• MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

  2007cited by this paper
• Characterizing the cancer genome in lung adenocarcinoma

  2007cited by this paper
• Apoptosis Induced by Depsipeptide FK228 Coincides with Inhibition of Survival Signaling in Lung Cancer Cells

  2007cited by this paper
• Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer.

  2007cited by this paper
• Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

  2007cited by this paper
• Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

  2007cited by this paper
• Downstream intracellular effectors of epidermal growth factor receptor as targets for anticancer therapy

  2007cited by this paper
• Global histone modifications predict prognosis of resected non small-cell lung cancer.

  2007cited by this paper
• Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

  2006cited by this paper
• Prognostic impact of p53 protein overexpression in patients with node-negative lung adenocarcinoma.

  2006cited by this paper
• Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.

  2006cited by this paper
• p16INK4A and CDH13 hypermethylation in tumor and serum of non‐small cell lung cancer patients

  2006cited by this paper
• Exclusive mutation in epidermal growth factor receptor gene, HER‐2, and KRAS, and synchronous methylation of nonsmall cell lung cancer

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors

  2006cited by this paper
• Somatic mutations of the ERBB4 kinase domain in human cancers

  2006cited by this paper
• Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

  2006cited by this paper
• Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.

  2006cited by this paper
• Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients.

  2006cited by this paper
• ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti‐cancer therapy

  2006cited by this paper
• Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras–MAPK signaling in human cancer cells

  2006cited by this paper
• Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors.

  2006cited by this paper
• HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.

  2006cited by this paper
• EGFR and erbB2 mutation status in Japanese lung cancer patients

  2006cited by this paper
• Methylation of RAS association domain family protein 1A as a biomarker of lung cancer

  2006cited by this paper
• LKB1 mutation in large cell carcinoma of the lung.

  2006cited by this paper
• The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.

  2006cited by this paper

• Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms

  2025cites this paper
• Unlocking the anticancer role of alpha-phellandrene via TRPM4 channel modulation in lung cancer

  2025cites this paper
• Noninvasive Disease Diagnostics: The Swiss Contribution Highlights to Breath Analysis Research

  2025cites this paper
• Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes

  2024cites this paper
• miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer

  2023cites this paper
• Impact of Electronic Cigarettes, Heated Tobacco Products and Conventional Cigarettes on the Generation of Oxidative Stress and Genetic and Epigenetic Lesions in Human Bronchial Epithelial BEAS-2B Cells

  2023cites this paper
• Identification of ALX3 Gene Promoter Hypermethylation as a Potential Biomarker for Lung Cancer

  2023cites this paper
• Epigenetics and precision medicine in lung cancer

  2022cites this paper
• The role of statins in lung cancer

  2021cites this paper
• Liquid biopsy uncovers distinct patterns of DNA methylation and copy number changes in NSCLC patients with different EGFR-TKI resistant mutations

  2021cites this paper
• The role of endothelial nitric oxide synthase gene polymorphisms in patients with lung cancer

  2020cites this paper
• Serum Folate Levels and Lung Cancer Risk: A Meta-Epidemiological Study of Population-based Case-Control Studies

  2020cites this paper
• Pharmacophore-based virtual screening for the identification of the novel Src inhibitor SJG-136 against lung cancer cell growth and motility.

  2020cites this paper
• Single-sample landscape entropy reveals the imminent phase transition during disease progression

  2020cites this paper
• Targeted Therapies in Veterinary Oncology.

  2019cites this paper
• Synergistic Effect of Novel EGFR Inhibitor AZD8931 and p38α siRNA in Lung Adenocarcinoma Cancer Cells.

  2019cites this paper
• Targeting the KRAS, p38α, and NF‐κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor

  2019cites this paper
• Single-sample landscape entropy reveals the imminent phase transition during disease progression.

  2019cites this paper
• Molecular/Targeted Therapy of Cancer

  2019cites this paper
• Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis

  2019cites this paper
• Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology

  2018influential citation
• Study on Association of BMI with Lung Cancer in North Indian Population

  2018cites this paper
• Multifunctional nanoparticles co‐delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non‐small‐cell lung tumor

  2017cites this paper
• Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters

  2017cites this paper
• The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases

  2017cites this paper
• Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ

  2017cites this paper
• CHEMOPREVENTIVE EFFECT OF HASKAP BERRY POLYPHENOLS AGAINST TOBACCO SPECIFIC NITROSAMINE-INDUCED DNA DAMAGE IN NORMAL LUNG EPITHELIAL CELLS IN VITRO

  2017cites this paper
• LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer.

  2017cites this paper
• DNA hypermethylation of tumor suppressor genes as an early lung cancer biomarker

  2016cites this paper
• The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis

  2016cites this paper
• MIIP accelerates epidermal growth factor receptor protein turnover and attenuates proliferation in non-small cell lung cancer

  2016cites this paper
• Lung cancer incidence in never smokers: Genetic and gender basis

  2016cites this paper
• Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results

  2015cites this paper
• Body mass index and risk of lung cancer: Systematic review and dose-response meta-analysis

  2015cites this paper
• Antitumor activity of 4-O-(2″-O-acetyl-6″-O-p-coumaroyl-β-D-glucopyranosyl)-p-coumaric acid against lung cancers via mitochondrial-mediated apoptosis.

  2015cites this paper
• 肺癌细胞中miR-182启动子甲基化状态研究

  2015cites this paper
• Epigenetic regulation of ANKRD18B in lung cancer

  2015cites this paper
• Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.

  2015cites this paper
• Semi-synthesis and anti-lung cancer activity evaluation of aryl dihydrothiazol acyl podophyllotoxin ester derivatives

  2015cites this paper
• Epigenetics and Epigenetic Therapy of Cancer

  2015cites this paper
• A Prospective Study of Tumor Suppressor Gene Methylation as a Prognostic Biomarker in Surgically Resected Stage I to IIIA Non–Small-Cell Lung Cancers

  2014cites this paper
• Predictive modeling of lung cancer recurrence using alternative splicing events versus differential expression data

  2014cites this paper
• In Vitro and in Vivo Antitumor Activity of Scutebarbatine A on Human Lung Carcinoma A549 Cell Lines

  2014cites this paper
• Epigenetic biomarkers in lung cancer.

  2014cites this paper
• Molecular Basis of Lung Cancer

  2014cites this paper
• Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation

  2014cites this paper
• Anti-proliferative of physcion 8-O-β-glucopyranoside isolated from Rumex japonicus Houtt. on A549 cell lines via inducing apoptosis and cell cycle arrest

  2014cites this paper
• Physicochemical Properties and Factors that Induce Asbestos-Related Respiratory Disease

  2014cites this paper
• Anti-tumor effect of polysaccharides from Scutellaria barbata D. Don on the 95-D xenograft model via inhibition of the C-met pathway.

  2014cites this paper
• Classification of lung cancer subtypes by data mining technique

  2014cites this paper
• Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes.

  2014cites this paper
• Genetic network and gene set enrichment analysis to identify biomarkers related to cigarette smoking and lung cancer.

  2013cites this paper
• Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.

  2013cites this paper
• The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancer

  2013cites this paper
• Diamond‐Lipid Hybrids Enhance Chemotherapeutic Tolerance and Mediate Tumor Regression

  2013cites this paper
• [Allelic imbalance in patients with non-small cell lung cancer].

  2013cites this paper
• Statins and the Risk of Lung Cancer: A Meta-Analysis

  2013cites this paper
• Kinase dysfunction and kinase inhibitors.

  2013cites this paper
• Inhibitory Effect of Polysaccharides from Scutellaria barbata D. Don on Invasion and Metastasis of 95-D Cells Lines via Regulation of C-MET and E-CAD Expressions

  2013cites this paper
• Molecular profiling in non-small cell lung cancer: a step toward personalized medicine.

  2013cites this paper
• EZH2 Promotes Malignant Behaviors via Cell Cycle Dysregulation and Its mRNA Level Associates with Prognosis of Patient with Non-Small Cell Lung Cancer

  2012cites this paper
• The Role of Sox Genes in Lung Morphogenesis and Cancer

  2012cites this paper
• Lung cancer in never smokers--a review.

  2012cites this paper
• From bedding to bedside: genetically engineered mouse models of cancer inform concurrent clinical trials

  2012cites this paper
• Genetic Susceptibility to Lung Cancer

  2012cites this paper
• Solid tumor cytogenetics: current perspectives.

  2011cites this paper
• Genomic pathology: challenges for implementation.

  2011cites this paper
• Pathologie und molekulare Pathologie von Lungentumoren

  2011cites this paper
• Molecular biology of lung cancer: clinical implications.

  2002influential citation